Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexlansoprazole for Heartburn During Ramadan
NCT03079050Phase 4Completed
- Sponsor
- American University of Beirut Medical Center
- Start
- Feb 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexlansoprazole in gastroesophageal reflux disease (GERD), sponsored by American University of Beirut Medical Center. Started Feb 2017; status: completed.
02
Drugs
dexlansoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT03079050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03079050.